Additional information
| Active substance | Anastrozole |
|---|---|
| Active Half-Life | 2 days |
| Classification | Non-steroidal aromatase inhibitor |
| Dosage | 0.5-1 mg/day |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitoring of liver enzymes and metabolic indicators may be required |
| Also known as | Olanzapine |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | May cause orthostatic hypotension |
| Trade name | Zyprexa |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine |
| Formula | C17H20N4S |
| Substance class | Thienobenzodiazepine |
| Main action | Antipsychotic |
| Half-life | Approximately 30 hours |
| Dosage (medical) | Typically 5-20 mg/day, adjusted based on patient response and condition |
| Dosage (sports) | Not applicable |
| Effects | Antipsychotic, mood stabilizing, reduction in agitation and hallucinations |
| Side effects | Weight gain, sedation, dry mouth, restlessness, elevated blood glucose levels |
| Use in sports | None |
| Manufacturer | Sandoz |
Reviews
There are no reviews yet.